SCHEMBL28651229

SCHEMBL28651229

O=C(O)N1CCN2Cc3cc(OC4CC4)c(Br)c(F)c3OC[C@H]2C1

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KRAS P01116 18/20 0.56
PDE4B Q07343 1/20 0.30
PDE4D Q08499 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28671279 0.88 KRAS (0.55) KRAS
SCHEMBL29693129 0.87 KRAS (0.54) KRASPDE4B
SCHEMBL24558375 0.87 KRAS (0.54) KRASPDE4B
SCHEMBL28656532 0.85 KRAS (0.54) KRAS
SCHEMBL28671533 0.84 KRAS (0.53) KRAS
SCHEMBL28654351 0.83 KRAS (0.55) KRAS
SCHEMBL28658835 0.83 KRAS (0.48) KRAS
SCHEMBL28664628 0.81 KRAS (0.46) KRAS
SCHEMBL28656559 0.81 KRAS (0.43) KRAS
SCHEMBL28928617 0.80 KRAS (0.55) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113508118-A Fused tricyclic compounds useful as anticancer agents 阿斯利康(瑞典)有限公司 2021-10-15 CN disclosed